Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Cost of Revenue: 2010-2025

Historic Cost of Revenue for Niagen Bioscience (NAGE) over the last 14 years, with Sep 2025 value amounting to $12.1 million.

  • Niagen Bioscience's Cost of Revenue rose 29.10% to $12.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.0 million, marking a year-over-year increase of 27.40%. This contributed to the annual value of $38.0 million for FY2024, which is 15.92% up from last year.
  • Latest data reveals that Niagen Bioscience reported Cost of Revenue of $12.1 million as of Q3 2025, which was up 10.72% from $10.9 million recorded in Q2 2025.
  • Over the past 5 years, Niagen Bioscience's Cost of Revenue peaked at $12.1 million during Q3 2025, and registered a low of $6.3 million during Q1 2021.
  • In the last 3 years, Niagen Bioscience's Cost of Revenue had a median value of $9.0 million in 2024 and averaged $9.5 million.
  • Per our database at Business Quant, Niagen Bioscience's Cost of Revenue spiked by 43.44% in 2021 and then decreased by 17.52% in 2022.
  • Over the past 5 years, Niagen Bioscience's Cost of Revenue (Quarterly) stood at $8.6 million in 2021, then fell by 17.52% to $7.1 million in 2022, then grew by 15.88% to $8.3 million in 2023, then surged by 32.32% to $10.9 million in 2024, then rose by 29.10% to $12.1 million in 2025.
  • Its Cost of Revenue was $12.1 million in Q3 2025, compared to $10.9 million in Q2 2025 and $11.2 million in Q1 2025.